In both AML and MDS, this region is frequently affected by loss of chromosome 7 or deletion of 7q—a karyotype associated with an adverse prognosis [30]—perhaps in part as a result of haploinsufficiency or loss of EZH2. This evidence concerns the gene EZH2 and myelodysplastic syndrome.